Pathogen Spectrum of Coronavirus Disease-2019(COVID-19)Associated Fungal Infection Patients of a Class A Tertiary Hospital
Objective To understand the spectrum of fungi of COVID-19 complicated with fungal infection patients in a third class A hospital from 10th December 2022 to 20th June 2023,providing pathogenic basis for COVID-19-associated fungal infections.Methods Retrospective analysis of the pathogen spectrum of COVID-19 is complicated by fungal infection patients,including the distribution of pathogens and sources of specimens and the correlation of fungi isolates with gender and age.All COVID-19 patients included in this study meet the confirmed diagnosis or clinical diagnosis criteria of invasive fungal infection.Identification of fungi uses the matrix-assisted laser desorption ionization time-of-flight Mass Spectrometry(MALDI-TOF-MS).For filamentous fungi were identified according to their colony and macroscopic characteristics and MALDI-TOF-MS.Results A total of 116 fungi were found in the 102 COVID-19 patients that were complicated by fungal infection between December 10,2022,and June 20,2023.The positive rates and strain numbers for Aspergillus,Candida,Rhizopus,and other classes were 57(49.41%),49(42.24%),4(3.45%),and 6(5.17%)respectively.14 patients were detected with two fungi.The detection of fungi in different age groups has statistical significance(P<0.001).There is statistical significance in the identification of Aspergillus and Aspergillus fumigatus indifferent gender groups(P=0.005 and P=0.008,respectively).The detection of Candida,Aspergillus,Candida albicans,Aspergillus flavus and Aspergillus fumigatusin different age groups has statistical significance(P<0.001,P<0.001,P=0.006,P<0.001 and P=0.009 respectively).The age group 80~90 years old had the second-highest constituent ratio(21.55%),after the 60~79 age group(62.93%).Conclusion Spectrum of fungi in COVID-19 patients were mainly candida and Aspergillus with Candida albicans and Aspergillus flavus being the most common,rare and important clinical fungi that should be paid attention to COVID-19 patients aged 60 years or above are susceptible to occur fungal co-infections.